These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8232588)
1. Bcl-2 associates with the ras-related protein R-ras p23. Fernandez-Sarabia MJ; Bischoff JR Nature; 1993 Nov; 366(6452):274-5. PubMed ID: 8232588 [TBL] [Abstract][Full Text] [Related]
2. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Portis T; Longnecker R Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852 [TBL] [Abstract][Full Text] [Related]
4. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells. Lindenboim L; Yuan J; Stein R Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212 [TBL] [Abstract][Full Text] [Related]
5. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Mei Y; Du W; Yang Y; Wu M Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132 [TBL] [Abstract][Full Text] [Related]
6. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Warne PH; Viciana PR; Downward J Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195 [TBL] [Abstract][Full Text] [Related]
7. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function. Kuo ML; Chou YW; Chau YP; Huang TS Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217 [TBL] [Abstract][Full Text] [Related]
8. Regulation of myeloid cell growth by distinct effectors of Ras. Matsuguchi T; Kraft AS Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Rebollo A; Pérez-Sala D; Martínez-A C Oncogene; 1999 Sep; 18(35):4930-9. PubMed ID: 10490827 [TBL] [Abstract][Full Text] [Related]
10. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32. Sunayama J; Ando Y; Itoh N; Tomiyama A; Sakurada K; Sugiyama A; Kang D; Tashiro F; Gotoh Y; Kuchino Y; Kitanaka C Cell Death Differ; 2004 Jul; 11(7):771-81. PubMed ID: 15031724 [TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. Brown DM; Phipps RP J Immunol; 1996 Aug; 157(4):1359-70. PubMed ID: 8759715 [TBL] [Abstract][Full Text] [Related]
12. p53 mediates bcl-2 phosphorylation and apoptosis via activation of the Cdc42/JNK1 pathway. Thomas A; Giesler T; White E Oncogene; 2000 Nov; 19(46):5259-69. PubMed ID: 11077443 [TBL] [Abstract][Full Text] [Related]
13. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Blagosklonny MV; Schulte T; Nguyen P; Trepel J; Neckers LM Cancer Res; 1996 Apr; 56(8):1851-4. PubMed ID: 8620503 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. Moreno MB; Memon SA; Zacharchuk CM J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614 [TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L). Yamochi T; Kaneita Y; Akiyama T; Mori S; Moriyama M Oncogene; 1999 Jan; 18(2):487-94. PubMed ID: 9927205 [TBL] [Abstract][Full Text] [Related]
17. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Ibrado AM; Liu L; Bhalla K Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074 [TBL] [Abstract][Full Text] [Related]
19. Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-4, but can interact with EGL-1. Jabbour AM; Puryer MA; Yu JY; Lithgow T; Riffkin CD; Ashley DM; Vaux DL; Ekert PG; Hawkins CJ J Cell Sci; 2006 Jun; 119(Pt 12):2572-82. PubMed ID: 16735440 [TBL] [Abstract][Full Text] [Related]
20. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Spector MS; Desnoyers S; Hoeppner DJ; Hengartner MO Nature; 1997 Feb; 385(6617):653-6. PubMed ID: 9024666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]